Genomics and Biological Activity of Neutrophil Gelatinase-Associated Lipocalin in Several Clinical Settings

Publisher： Karger

E-ISSN： 1421-9735|35|1-3|139-143

ISSN： 0253-5068

Source： Blood Purification, Vol.35, Iss.1-3, 2013-01, pp. : 139-143

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Clinical Utility of Plasma Neutrophil Gelatinase-Associated Lipocalin in Acute Kidney Injury

By  

Blood Purification, Vol. 35, Iss. 4, 2013-05 ,pp. : 295-302

Karger

Access to resources Recommend Favorite

Neutrophil Gelatinase-Associated Lipocalin: Ready for Routine Clinical Use? An International Perspective

By  

Blood Purification, Vol. 37, Iss. 4, 2014-07 ,pp. : 271-285

Karger

Access to resources Recommend Favorite

Neutrophil Gelatinase-Associated Lipocalin: A Novel Early Urinary Biomarker for Cisplatin Nephrotoxicity

By  

American Journal of Nephrology, Vol. 24, Iss. 3, 2004-07 ,pp. : 307-315

Karger

Access to resources Recommend Favorite

Neutrophil Gelatinase-Associated Lipocalin as an Early Biomarker of Nephropathy in Diabetic Patients

By  

Kidney and Blood Pressure Research, Vol. 32, Iss. 2, 2009-03 ,pp. : 91-98

Karger

Access to resources Recommend Favorite

Neutrophil Gelatinase-Associated Lipocalin as a Biomarker of Acute Kidney Injury in Patients with Morbid Obesity Who Underwent Bariatric Surgery

By  

Nephron Extra, Vol. 3, Iss. 1, 2013-10 ,pp. : 101-105

Karger

Access to resources Recommend Favorite